Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acadia Pharmaceutica (ACAD)

   0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.305 - 41.642 41.642 - 41.868
Low: 39.228 - 39.596 39.596 - 39.843
Close: 39.748 - 40.318 40.318 - 40.701

Technical analysis

as of: 2020-08-11 4:29:00 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 59.82     One year: 68.16
Support: Support1: 39.66    Support2: 33.00
Resistance: Resistance1: 51.22    Resistance2: 58.36
Pivot: 42.78
Moving Average: MA(5): 42.15     MA(20): 45.33
MA(100): 47.24     MA(250): 43.36
MACD: MACD(12,26): -2.35     Signal(9): -2.06
Stochastic oscillator: %K(14,3): 13.82     %D(3): 15.09
RSI: RSI(14): 32.79
52-week: High: 58.72  Low: 23.77  Change(%): 38.2
Average Vol(K): 3-Month: 180917  10-Days: 150961

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ACAD has closed below the lower band by 12.1%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACAD's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 06 Aug 2020
ACADIA (ACAD) Q2 Earnings Surpass, Nuplazid Drives Sales - Nasdaq

Thu, 06 Aug 2020
Analysts Have Conflicting Sentiments on These Healthcare Companies: Enanta Pharmaceuticals (NASDAQ: ENTA), Perrigo Company (NYSE: PRGO) and ACADIA Pharmaceuticals (NASDAQ: ACAD) - Analyst Ratings

Thu, 06 Aug 2020
Analysts Offer Insights on Healthcare Companies: Aileron Therapeutics (ALRN), ACADIA Pharmaceuticals (ACAD) and Globus Medical (GMED) - Smarter Analyst

Wed, 05 Aug 2020
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings - Benzinga

Sun, 02 Aug 2020
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings - Benzinga

Thu, 30 Jul 2020
SHAREHOLDER ALERT: Stephens & Stephens LLP Investigating the Officers and Directors of ACADIA Pharmaceuticals Inc. (ACAD) - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 156
Shares Float (M) 114
% Held by Insiders 0.10
% Held by Institutions 97.57
Shares Short (K) 9,820
Shares Short P. Month (K) 11,230

Stock Financials

EPS -1.590
EPS Est This Year -2.550
EPS Est Next Year -1.960
Book Value (p.s.) 4.110
Profit Margin -64.99
Operating Margin -67.84
Return on Assets (ttm) -24.9
Return on Equity (ttm) -45.0
Qtrly Rev. Growth 43.1
Gross Profit (p.s.) 0.507
Sales Per Share 2.349
EBITDA (p.s.) -1.577
Qtrly Earnings Growth
Operating Cash Flow (M) -136
Levered Free Cash Flow (M) -54

Stock Valuations

PE Ratio -25.30
PEG Ratio
Price to Book value 9.79
Price to Sales 17.12
Price to Cash Flow -46.12

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.